Insider trading · Q3 2026 · CIK 73290

Biomerica Inc (BMRA) insider trading.

In Q3 2026, insiders at Biomerica Inc reported 5 non-derivative transactions on 7 Forms 3, 4 and 5: 5 open-market purchases worth $158K and 0 sales.

Transactions
5
Purchases (P)
5
Sales (S)
0
Net shares, P minus S
98,750
Insiders
5
Last filed
2026-08-27

Insiders

InsiderRelationshipTransactionsBuysSales
Irani Zackary S.Director, Officer · Chief Executive Officer110
Barbieri AllenDirector, Officer · Executive Vice Chairman110
Chin EricDirector110
Moatazedi DavidDirector110
Gary M. HuffDirector110

Transactions

5 non-derivative rows, newest transaction first. Shares and prices as filed.
DateInsiderCodeSharesPriceOwned afterFiling
2026-08-26Irani Zackary S.P (A)31,250$1.6242,570Form 4
2026-08-26Barbieri AllenP (A)20,000$1.673,542Form 4
2026-08-26Chin EricP (A)6,250$1.638,750Form 4
2026-08-26Moatazedi DavidP (A)10,000$1.640,625Form 4
2026-08-20Gary M. HuffP (A)31,250$1.651,250Form 4

Transaction codes in this quarter

Get BMRA insider transactions through the API

Request with your API key
curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=73290&limit=100" \
  -H "Authorization: Bearer $SEC_API_KEY"

Insider trading API guide · BMRA company page · Biomerica Inc on SEC.gov

Questions

Are insiders buying or selling Biomerica Inc (BMRA)?

In Q3 2026, insiders at Biomerica Inc reported 5 non-derivative transactions on 7 Forms 3, 4 and 5: 5 open-market purchases worth $158K and 0 sales. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.

Where do these Biomerica Inc insider trades come from?

From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.

Source: SEC Insider Transactions Data Sets, Q3 2026, retrieved 2026-10-27. Footnotes, derivative holdings and amendments are in the linked filings. Not investment advice.

Plain-text version for agents and LLMs: /insider-trading/bmra.md

Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.